Skip to main content
Premium Trial:

Request an Annual Quote

Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers

NEW YORK – Fulgent Genetics has announced a partnership with telehealth firm PWNHealth to provide oversight for a new line of genetic tests marketed to consumers.

Fulgent today launched Picture Genetics, a trio of at-home genetic tests for consumers. PWNHealth will provide physician review and genetic counseling for these tests.

Financial and other terms of the partnership were not disclosed.

"We are very excited about the launch of Picture Genetics, our consumer-initiated test offering, which enables us to deliver our advanced genetic testing capabilities to a much broader audience in an accessible manner," Fulgent CEO Ming Hsieh said in a statement. "We believe our line of tests offers one of the most comprehensive at-home screening options available in the market, given the inclusion of genetic counseling as well as involvement from independent physicians."

Based in Temple City, California, Fulgent offers a large catalog of clinical genetic tests performed with next-generation sequencing technology.

PWNHealth, based in New York, also offers oversight of consumer-driven tests for other firms, including Sema4 and Lineagen.

Picture Parenting, a carrier screening test priced at $295, is the only test in the new line that is immediately available. Picture Newborn and Picture Wellness, tests for health risks based on genetic markers, "will be available in the coming months," Fulgent said in a statement.

Fulgent said the tests are completed at home, "without the need for a doctor visit or insurance," and will provide "medically actionable, clinical-level results with professional medical follow-up."

In August, Fulgent received approval from the New York State Department of Health to offer its next-generation sequencing tests in the state.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.